Rezultati - Pierre Combe
- Showing 1 - 11 results of 11
-
1
-
2
-
3
Base-Position Error Rate Analysis of Next-Generation Sequencing Applied to Circulating Tumor DNA in Non-Small Cell Lung Cancer: A Prospective Study od Nicolas Pécuchet, Eleonora Zonta, Audrey Didelot, Pierre Combe, Constance Thibault, Laure Gibault, Camille Lours, Yves Rozenholc, Valérie Taly, Pierre Laurent–Puig, Hélène Blons, Elizabeth Fabre
Izdano 2016Artigo -
4
Analysis of Base-Position Error Rate of Next-Generation Sequencing to Detect Tumor Mutations in Circulating DNA od Nicolas Pécuchet, Yves Rozenholc, Eleonora Zonta, Daniel Pietrasz, Audrey Didelot, Pierre Combe, Laure Gibault, Jean‐Baptiste Bachet, Valérie Taly, Elizabeth Fabre, Hélène Blons, Pierre Laurent‐Puig
Izdano 2016Artigo -
5
VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors od Thibault Voron, Orianne Colussi, Elie Marcheteau, Simon Pernot, Mevyn Nizard, Anne‐Laure Pointet, Sabrina Latreche, Sonia Bergaya, Nadine Benhamouda, Corinne Tanchot, Christian Stockmann, Pierre Combe, Anne Berger, Franck Zinzindohoué, Hideo Yagita∥, Éric Tartour, Julien Taı̈eb, Magali Terme
Izdano 2015Artigo -
6
Tim-3 Expression on Tumor-Infiltrating PD-1+CD8+ T Cells Correlates with Poor Clinical Outcome in Renal Cell Carcinoma od Clémence Granier, Charles Dariane, Pierre Combe, Virginie Verkarre, Saı̈k Urien, Cécile Badoual, Hélène Roussel, Marion Mandavit, Patrice Ravel, Mathilde Sibony, Lucie Biard, C. Radulescu, Emeline Vinatier, Nadine Benhamouda, Michaël Peyromaure, Stéphane Oudard, Arnaud Méjean, Marc‐Olivier Timsit, Alain Gey, Éric Tartour
Izdano 2016Artigo -
7
CA-125 ELIMination Rate Constant K (KELIM) Is a Marker of Chemosensitivity in Patients with Ovarian Cancer: Results from the Phase II CHIVA Trial od Benoît You, Patrick Robelin, Michel Tod, Christophe Louvet, Jean‐Pierre Lotz, Sophie Abadie‐Lacourtoisie, Michel Fabbro, Christophe Desauw, Nathalie Bonichon-Lamichhane, Jean‐Emmanuel Kurtz, Philippe Follana, Marianne Leheurteur, Francesco Del Piano, Gwénaël Ferron, Gaëtan De Rauglaudre, Isabelle Ray‐Coquard, Pierre Combe, Annick Chevalier-Place, Florence Joly, Alexandra Léary, Éric Pujade-Lauraine, Gilles Freyer, Olivier Colomban
Izdano 2020Artigo -
8
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer od Isabelle Ray‐Coquard, Patricia Pautier, Sandro Pignata, David Pérol, Antonio González-Martı́n, Regina Berger, Keiichi Fujiwara, Ignace Vergote, Nicoletta Colombo, Johanna Mäenpää, Frédèric Selle, Jalid Sehouli, Domenica Lorusso, Eva Maria Guerra Alía, Alexander Reinthaller, Shoji Nagao, Claudia Lefeuvre‐Plesse, Ulrich Canzler, Giovanni Scambia, Alain Lortholary, Frederik Marmé, Pierre Combe, Nikolaus de Gregorio, Manuel Rodrigues, Paul Buderath, Coraline Dubot, Alexander Burges, Benoît You, Éric Pujade-Lauraine, Philipp Harter
Izdano 2019Artigo -
9
Pemigatinib for patients with previously treated, locally advanced or metastatic cholangiocarcinoma harboring FGFR2 fusions or rearrangements: A joint analysis of the French PEMI-B... od Alessandro Parisi, Blandine Delaunay, Giada Pinterpe, Antoine Hollebecque, Jean Frédéric Blanc, Mohamed Bouattour, Eric Assenat, Méher Ben Abdelghani, Matthieu Sarabi, Monica Niger, Caterina Vivaldi, Mario Mandalà, Andrea Palloni, Maria Bensi, Silvio Ken Garattini, David Tougeron, Pierre Combe, Massimiliano Salati, Margherita Rimini, Chiara Alessandra Cella, Marco Tucci, Anna Diana, Elena Mori, Raffaella Longarini, Pascal Artru, Gaël Roth, Ludovic Evesque, A Vienne, Anthony Turpin, Sandrine Hiret, Vincent Bourgeois, Camille Hervé, Rodolphe Paulon, Marion Stacoffe, David Malka, Cindy Neuzillet, Julien Edeline, Astrid Lièvre, Rosine Guimbaud, Marie Christelle Pajiep Chapda, Lorenza Rimassa, Riccardo Giampieri, Juan W. Valle, Rossana Berardi, Nadim Farés
Izdano 2024Artigo -
10
Cemiplimab for Locally Advanced and Metastatic Cutaneous Squamous-Cell Carcinomas: Real-Life Experience from the French CAREPI Study Group od C. Hober, Lisa Fredeau, Anne Pham‐Ledard, Marouane Boubaya, F. Herms, P. Célérier, F. Aubin, N. Bénéton, Monica Dinulescu, A. Jannic, Nicolás Meyer, Anne-Bénédicte Duval-Modeste, Laure Césaire, Eve‐Marie Neidhardt, E. Archier, Brigitte Dréno, C. Lesage, C. Berthin, N. Kramkimel, Florent Grange, Julie De Quatrebarbes, Pierre‐Emmanuel Stoebner, Nicolas Poulalhon, Jean‐Philippe Arnault, Safia Abed, B. Bonniaud, Sophie Darras, Valentine Heidelberger, S. Devaux, M. Moncourier, L. Misery, Sandrine Mansard, M. Étienne, F. Brunet‐Possenti, C. Jacobzone, Romain Lesbazeilles, F. Skowron, J. Sanchez, Stéphanie Catala, M. Samimi, Youssef Tazi, Dominique Spaëth, C. Gaudy‐Marqueste, Olivier Collard, Raoul Triller, Marc Pracht, Marc‐Emmanuel Dumas, L. Peuvrel, Pierre Combe, O. Lauche, Pierre Guillet, Yves Réguerre, I. Kupfer‐Bessaguet, D. Solub, A. Schoeffler, Christophe Bédane, G. Quéreux, S. Dalac, Laurent Mortier, E. Maubec
Izdano 2021Artigo -
11
Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial od Jean‐Emmanuel Kurtz, Éric Pujade-Lauraine, Ana Oaknin, Lisa Belin, Katharina Leitner, David Cibula, Hannelore Denys, Ora Rosengarten, Manuel Rodrigues, Nikolaus de Gregorio, Jerónimo Martínez, Edgar Petru, Roman Kocián, Ignace Vergote, Patricia Pautier, Barbara Schmalfeldt, Lydia Gaba, Stephan Polterauer, Marie‐Ange Mouret‐Reynier, Jalid Sehouli, Cristina Churruca, Frédèric Selle, Florence Joly, Véronique D’Hondt, Émilie Bultot-Boissier, Coriolan Lebreton, Jean‐Pierre Lotz, Rémy Largillier, Pierre-Étienne Heudel, Florian Heitz, Jean‐Emmanuel Kurtz, Sophie Abadie‐Lacourtoisie, Cyril Abdeddaim, J. Alexandre, P. Augereau, D. Avenin, M. Azémar, Nabil Baba-Hamed, Olivia Bally, Jérôme Barrière, Fernando Bazán, Dominique Berton, Nathalie Bonichon-Lamichhane, Nathalie Bonnin, Elouen Boughalem, R. Boustany Grenier, Pierre-Emmanuel Brachet, Fabien Brocard, Émilie Bultot-Boissier, Maria Cappiello-Bataller, Hélène Castanie, L. Chaigneau, Camille Chakiba, Dorothée Chocteau-Bouju, Pierre Combe, Aurélie Comte, Elodie Coquan, Cristina Costan, P. Cottu, L. Crouzet, H. Curé, Jérôme Dauba, Hussain Dawood, Laure De Cock, T. De La Motte Rouge, C. Debelleix, Catherine Delbaldo, Martin Demarchi, Marion Deslandres, Raymond Despax, Véronique D’Hondt, Anne Françoise DILLIES-LEGRAIN, A Donnadieu, C. Dubot, Jean Marc Extra, Michel Fabbro, Claire Falandry, F. Fiteni, Anne Floquet, Philippe Follana, Jean‐Sébastien Frénel, G. Freyer, D. Garbay-Decoopman, C. Gavoille, V. Girre, Laurence Gladieff, F. Goldwasser, Alain Gratet, Jean‐Christophe Grenier, Anne‐Claire Hardy‐Bessard, Pierre-Étienne Heudel, Florence Joly, A. Jouinot, Emilie Kalbacher, Marie‐Christine Kaminsky, Laurence Lancry-Lecomte, R. Largillier, Fanny Le Du, Alexandra Léary, Coriolan Lebreton
Izdano 2023Artigo
Iskalna orodja:
Sorodne teme
Medicine
Internal medicine
Oncology
Biology
Cancer
Biochemistry
Chemotherapy
Ovarian cancer
Cancer research
Gene
Bevacizumab
CD8
Cell biology
Confidence interval
Cytotoxic T cell
Digital polymerase chain reaction
Genetics
Immune system
Immunology
Immunotherapy
In vitro
Lung cancer
Multivariate analysis
Polymerase chain reaction
Progression-free survival
T cell
Abdominal aortic aneurysm
Adverse effect
Allele
Allele frequency